🚀 Biotech Moonshot Analytics

AI-Powered Venture Portfolio Intelligence
Multi-horizon transformer models + real-time risk filters = systematic detection of micro/small-cap biotech moonshots

📰 Latest Newsletter

Current moonshot opportunities with risk-adjusted scores, catalyst signals, and model rankings across 30d/90d/180d/365d horizons.

View Current Newsletter

📊 Track Record

Historical performance of moonshot predictions. Micro-cap: 24.3% moonshot rate | Small-cap: 16.4% moonshot rate.

See Performance SOON

🏢 Company Deep Dives

Detailed analysis of individual companies including model reasoning, risk assessment, and catalyst timeline.

Browse Companies SOON

System Overview

15,000+
SEC Filings Analyzed
186
Biotech Companies
0.30
Information Coefficient
180+
Feature Primitives

How it works:

  1. Long-term opportunity detection - Transformer models trained on 15,000+ SEC filings (186 companies, ~85 filings each) identify temporal patterns across 30d/90d/180d/365d
  2. Catastrophic risk filter - Rule-based detection of trial failures, going concern warnings, clinical holds (FATAL risks removed)
  3. Catalyst opportunity detector - Rule-based signals for breakthrough therapy, partnerships, FDA fast track designation
  4. Risk-adjusted scoring - Base moonshot score adjusted for risk level and catalyst strength

🧬 Biotech Moonshot Analytics | Powered by VentureTransformer Architecture

Systematic detection of asymmetric opportunities in micro/small-cap biotech